https://twitter.com/Colwellinvestor
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nope but excited to watch!
Nice finally some volume.
Dont they have until the 27th for the acquisition?
Up to 15 days for merger completion
This will hit .10 once financing is approved. Company has up to 45 days left to acquire FemCap
Nice bid support! 276k at .01
The founder of FemCap wants to be absorbed into the company, not looking to just sell his patients.
Also there has been little to no dilution! Very rare in this market.
Agreed, no fluff PRs needed here. Also no need to harass the CEO with emails or phone calls.
We will know by 8/26 at the latest. My guess is mid July financing is approved for the acquisition
Only 35k shares to .02. Never seen such a thinly traded stock before. Next update this is going to go parabolic!
I bet nite only has 10k shares
Bid and Ask spread is crazy. Over 100% difference
Going to turn $10k into $100k with this stock. 10 bagger once the acquisition is completed.
Not sure, but I'm def loading at this PPS.
Got my average from .025 down to .02 this week. Almost at my 500k share goal.
No one wants to bid whack 100k @.0125?
I'm bid sitting. Adding cheap shares to my collection. Will start ask slapping when volume picks up or when an update is released.
LOI said up to 90 days to complete the acquisition. It hasn't even been 30 days yet....
Last update from the company was just 13 days ago. If we don't hear anything for another 30-40 days then I might start wonder what's up.
Haven't tried to email or call. Update is coming soon, patience my friend.
Rare find, an OTC stock with no dilution! Just need some merger completion news!
I got some funds xfering. Ready to load another 100k tomorrow
Wow only 81k on the ask to .05.
4 PRs and a 10q in the last 30 days, I'd say this company is fairly transparent. Take advantage of low volume and load more before the next update
May 26th
I'm going to add another 100k next week! Still trying to get 500k before the next update.
Looks like I'm going to have to slap the ask if I want more shares. No one wants to sell into the bid...
Buying pressure is building
Wow bid is really starting to stack up!
97k shares to .025. Super thin!
Keep chipping away at that ask! Would be nice to be at .025+ before the next update is released.
Agree, $LFAP contracted with Cornerstone for financial and merger assistance 2 weeks ago. Will need to raise 3.5 mil to complete the merger. 2 mil for the acquisition and 1.5 mil for marketing and product development.
Meet the new alternative to a condom! A non hormonal contraceptive that prevents STDs, without sacrificing his or her pleasure!
PatePublication numberUS20080121238 A1Publication typeApplicationApplication numberUS 11/564,793Publication dateMay 29, 2008Filing dateNov 29, 2006Priority dateNov 29, 2006Also published asUS20090320855, WO2008067458A2,WO2008067458A3InventorsAlfred A. ShihataOriginal AssigneeShihata Alfred AExport CitationBiBTeX, EndNote, RefManPatent Citations (13), Classifications (7), Legal Events (1)External Links: USPTO, USPTO Assignment, Espacenet
Kit for Contraception and Prevention of Sexually Transmitted Infections
US 20080121238 A1
ABSTRACT
The present invention relates to a kit for the prevention of conception and infection by sexually transmitted infections, said kit comprising the combination of a barrier-type device, a vaginal applicator, and a prophylactic agent. The present invention also relates to a barrier-type device for the prevention of conception and infection by sexually transmitted infections. The present invention also relates to a vaginal applicator useful for depositing a prophylactic agent in divided doses and in multiple directions over the barrier-type device and over a desired area of the cervix and the vagina.
IMAGES(4)
CLAIMS(17)
1. A barrier-type device for prevention of conception and sexually transmitted infection, comprising:
a cervical dome fabricated from a flexible material, said dome having an upwardly facing opening and a curved surface extending from said opening to a downwardly facing dome peak, and
a continuous, generally annular formical rim defining said opening, said rim being folded from said dome inwardly, upwardly, and outwardly, transitioning therefrom into a continuous, annular vaginal brim which circumscribes said cervical dome and extends both outwardly and downwardly, said formical rim thereby forming an inwardly extending lip and a gel trapping, inwardly extending groove between said brim and said lip, and
a removal strap extending across the dome over the downwardly facing dome peak.
2. A vaginal applicator for depositing a prophylactic agent over a desired area of the vagina, comprising:
a reservoir for holding the prophylactic agent, said reservoir having a proximal end and a distal end, and
a perforated tip attached to the distal end, and
plunger means attached to the proximal end.
3. The applicator of claim 2, wherein the reservoir is filled with the prophylactic agent from its proximal end.
4. The applicator of claim 2, wherein the reservoir is filled with the prophylactic agent from its distal end.
5. The applicator of claim 2, wherein the perforated tip is permanently attached to the distal end.
6. The applicator of claim 2, wherein the perforated tip is removably attached to the distal end.
7. The applicator of claim 2 that is single use.
8. The applicator of claim 2 that is reusable.
9. The applicator of claim 2, wherein the prophylactic agent is deposited into a desired area of the vagina in one step.
10. The applicator of claim 2, wherein the prophylactic agent is deposited into a desired area of the vagina in divided doses by multiple steps.
11. A kit for prevention of conception and sexually transmitted infection, comprising, in combination:
a barrier-type device for prevention of conception and sexually transmitted infection, comprising:
a cervical dome fabricated from a flexible material, said dome having an upwardly facing opening and a curved surface extending from said opening to a downwardly facing dome peak, and
a continuous, generally annular formical rim defining said opening, said rim being folded from said dome inwardly, upwardly, and outwardly, transitioning therefrom into a continuous, annular vaginal brim which circumscribes said cervical dome and extends both outwardly and downwardly, said formical rim thereby forming an inwardly extending lip and a gel trapping, inwardly extending groove between said brim and said lip, and
a removal strap extending across the dome over the downwardly facing dome peak; and
a vaginal applicator for depositing a prophylactic agent over a desired area of the vagina, comprising:
a reservoir for holding the prophylactic agent, said reservoir having a proximal end and a distal end, and
a perforated tip attached to the distal end, and
plunger means attached to the proximal end; and
a prophylactic agent for deposition over a desired area of the vagina.
12. The kit of claim 11, wherein the prophylactic agent is selected from a group consisting of: a spermicide, a microbicide, and a virucide.
13. The kit of claim 12, wherein the spermicide or microbicide is Acidform® (Amphora®).
14. The kit of claim 11, wherein the prophylactic agent is a combination of a spermicide and a peroxygen compound.
15. The kit of claim 14, wherein the peroxygen compound is hydrogen peroxide.
16. The kit of claim 11, wherein the prophylactic agent is in the form selected from the group consisting of: a cream, a gel, a jelly, and a foam.
17. The kit of claim 11, wherein the prophylactic agent is deposited over a desired area of the vagina, said area selected from the group consisting of: cervix and vaginal walls.
DESCRIPTION
FIELD OF THE INVENTION
[0001]
The present invention relates to the field of contraception and prevention of sexually transmitted infections. In particular, the present invention relates to a kit for the prevention of conception and infection by sexually transmitted infections, said kit comprising the combination of a barrier-type device, a vaginal applicator, and a prophylactic agent. The present invention also relates to a barrier-type device for the prevention of conception and infection by sexually transmitted infections. The present invention also relates to a vaginal applicator useful for depositing a prophylactic agent over the barrier-type device and over a desired area of the vagina and the cervix.
BACKGROUND OF THE INVENTION
[0002]
The prior art devices for intravaginal, barrier-type prevention of conception and sexually transmitted infections include the diaphragm and the cervical cap. The diaphragm, when positioned intravaginally, acts as a mechanical barrier to prevent sperm from entering the os of the cervix. A spermicide is typically used on the bowl of the diaphragm facing the cervix to kill sperm traversing over the edge of the diaphragm. Typically, the diaphragm is a shallow rubber cup with a rim. A round, coiled metal spring is disposed in the rim. The diaphragm is intended for intravaginal position between the posterior aspect of the pubic bone and the posterior fornix. When such positioned, the diaphragm presses against the vaginal wall to form a continuous mechanical barrier therewith.
[0003]
The cervical cap is a small, vaulted or domed device, typically scaled to fit over a cervix, where it is retained in place by suction. In contrast, the diaphragm is retained in place by spring tension. The cervical cap includes a dome which rises from a rim. The cap is slipped over the cervical protrusion to block access to the uterus through the cervical os.
[0004]
Unfortunately, traditional diaphragm and cervical cap devices are not adapted to seal closely the space between the vagina and the cervix. The diaphragm is held against the upper part of the vaginal canal by tension of the spring in its rim, while the cervical cap typically engages only the tip of the cervix. Both of these prior art devices may be dislodged by a variety of factors, such as sexual arousal, coital activity, or orgasm. It is established that dislodgment of the device reduces the effectiveness of the barrier and permits unintended conception or infection.
[0005]
In failing to take into account the anatomy and physiology of the vagina and the cervix, the prior art devices form imperfect barriers against the penetration of sperm and agents of sexually transmitted infections into the uterus. It is well known that fertilization and infection take place within the uterus; therefore a more effective barrier blocking access to the cervical os provides greater protection from unwanted fertilization or infection following sexual intercourse.
[0006]
With the emergence of the AIDS epidemic, there is a compelling need for intravaginal, barrier-type devices which are capable of decreasing the risk of infection by significantly increasing the effectiveness and reliability of the barrier to entry of bodily fluids as such as semen into the cervix.
[0007]
U.S. Pat. No. 4,858,624 discloses a barrier-type device which is intended to be placed over the cervix to block entry of bodily fluids into the cervix. While an improvement over the prior art barrier-type devices, the device is intended to be positioned in the vagina by means of a special inserter. Such positioning is cumbersome and requires the use of a special inserter. Moreover, since the device lacks any internal removal means, its removal presents an additional difficulty to the user. The user has to manually reach inside the vagina and attempt to remove the device by applying pressure on the rim of the device in order to break the suction between the device and the cervix. Such manual removal of the device presents risk of physically injuring the interior of the vagina by finger nail scratching.
[0008]
U.S. Pat. No. 5,207,232 discloses a kit for intravaginal, barrier-type prevention of conception and sexually transmitted infection, said kit comprising a barrier-type device and an inserter. While an improvement over the prior art barrier-type devices, the device suffers from many of the same problems shared by the device disclosed in U.S. Pat. No. 4,858,624. Specifically, it is cumbersome to insert and remove, presence of the inserter adds a risk of injury to the vagina, and manual removal of the device presents an additional risk of injury to the vagina.
[0009]
It is one objective of the present invention to provide an intravaginal, barrier type device which provides for a more perfect and reliable coverage of the cervix intended to prevent the entry of sperms and infectious agents from the vaginal canal through the cervical os into the uterus. It is another objective of the present invention to provide an intravaginal, barrier-type device which can be easily inserted and removed manually, without the need of any additional inserter, and without an increased risk of vagina injury.
[0010]
It is well known in the art of contraception that spermicidal compositions are useful to protect against pregnancy. They can be typically used alone, with a mechanical barrier-type device such as a diaphragm, cervical cap, or sponge, or an in addition to other contraceptive methods. However, unfortunately, spermicidal compositions such as nonoxynol-9 also have a significant side effect in that they destroy the natural and safe biological environment of the cervix and vagina, often resulting in cervical and vaginal damage, which in turn increases the woman's susceptibility to sexually transmitted infections.
[0011]
It is desirable to use the spermicidal compositions in conjunction with intravaginal barrier-type devices to increase the success of preventing conception and sexually transmitted infection. One common problem associated with prior art devices is that spermicidal compositions applied onto or into the bowl of the device facing the cervix cause irritation to the cervix. Furthermore, the spermicidal composition originally deposited on the device first leaks outside the vagina, where it causes vaginal irritation, and then ultimately becomes ejected from the vagina, decreasing the contraceptive and anti-infectious efficacy of the spermicide. It is one objective of the present invention to provide an intravaginal barrier-type device that holds the deposited spermicide in place and prevents it from leaking and irritating the vagina.
[0012]
Spermicidal compositions are typically deposited directly into the vagina or onto the intravaginal barrier-type device by means of an applicator. Prior art applicators generally consist of a reservoir having a proximal end and a distal end, a plunger or other ejection means attached to the proximal end, and a tip attached to the distal end. The reservoir is generally filled from the distal end. The spermicidal composition is generally deposited to a target area by applying pressure to the plunger or other ejection means attached to the proximal end, such that the spermicidal composition inside the reservoir travels toward the tip attached to the distal end and finally is ejected from the tip into the target area. One problem common to prior art applicators is that the spermicidal composition is ejected from a single opening in the tip attached to the distal end of the reservoir. Therefore, the ejected spermicide travels in one path and covers a relatively limited area. It is desirable to spread the spermicide or microbicide as widely as possible throughout the desired target area in order to provide a maximum amount of protection against conception and sexually transmitted infection. Users of prior art applicators typically attempt to augment this problem by depositing additional doses of spermicide or microbicide. This method is undesirable because the spermicide or microbicide is deposited in a relatively limited area and soon will be expelled from the vagina, thus increasing the chance of vaginal irritation due to the spermicide spillage outside of the vagina.
[0013]
Therefore, it is a further objective of the present invention to provide a vaginal applicator that ejects spermicidal or microbicidal compositions in divided doses and in multiple directions, and thus deposits a single dose of spermicide over a wider area than prior art applicators. Yet further objectives of the present invention will become apparent from a consideration of the following description.
SUMMARY OF THE INVENTION
[0014]
In one aspect, the present invention is directed to an intravaginal barrier-type device for prevention of conception and sexually transmitted infection. In another aspect, the present invention is directed to an intravaginal barrier-type device that covers the cervix. In another aspect, the present invention is directed to an intravaginal barrier type-device for prevention of conception and sexually transmitted infection, such device comprising a cervical dome fabricated from a flexible material, said dome having an upwardly facing opening and a curved surface extending from said opening to a downwardly facing dome peak, a continuous, generally annular formical rim defining said opening, said rim being folded from said dome inwardly, upwardly, and outwardly, transitioning therefrom into a continuous, annular vaginal brim which circumscribes said cervical dome and extends both outwardly and downwardly, said formical rim thereby forming an inwardly extending lip and a gel trapping, inwardly extending groove between said rim and said lip, and a strap extending across the dome over the downwardly facing dome peak
[0015]
In another aspect, the present invention is directed to a vaginal applicator for depositing a prophylactic agent onto a desired target area. In one aspect of the present invention, the desired target area is the exterior surface of the intravaginal barrier-type device. In another aspect, the desired target area is the cervix and the vagina. In yet another aspect, the vaginal applicator comprises a reservoir for holding the prophylactic agent, said reservoir having a proximal end and a distal end, a perforated tip attached to the distal end, and plunger means attached to the proximal end.
[0016]
In yet another aspect, the present invention is directed to a kit for prevention of conception and sexually transmitted infection. In one aspect, the kit comprises a combination of a barrier-type device for prevention of conception and sexually transmitted infection, a vaginal applicator, and a prophylactic agent. In another aspect, the kit comprises a combination of (a) a barrier-type device for prevention of conception and sexually transmitted infection, comprising a cervical dome fabricated from a flexible material, said dome having an upwardly facing opening and a curved surface extending from said opening to a downwardly facing dome peak, and a continuous, generally annular formical rim defining said opening, said rim being folded from said dome inwardly, upwardly, and outwardly, transitioning therefrom into a continuous, annular vaginal brim which circumscribes said cervical dome and extends both outwardly and downwardly, said formical rim thereby forming an inwardly extending lip and a gel trapping, inwardly extending groove between said brim and said lip, and a strap extending across the dome over the downwardly facing dome peak; and (b) a vaginal applicator for depositing a prophylactic agent over a desired area of the cervix and the vagina, comprising a reservoir for holding the prophylactic agent, said reservoir having a proximal end and a distal end, a perforated tip attached to the distal end, and plunger means attached to the proximal end; and (c) a prophylactic agent for deposition onto a desired target area.
[0017]
These and other features, aspects, and advantages of the present invention will become better understood with reference to the following description and claims.
BRIEF DESCRIPTION OF THE DRAWINGS
[0018]
The present invention will become better understood with reference to the specification, appended claims, and accompanying drawings, where:
NUMBERING REFERENCE LIST
[0000]
10. Cervix12. Rim14. Femcap16. Brim18. Dome20. Removal strap22. Vagina24. Bowl6. Cross-section of the Femcap at level26. Groove28. Lip30A. Vaginal applicator embodiment A30B. Vaginal applicator embodiment B32. Handle of the barrel34. Barrel36. Tip of the barrel38. Oval perforations40. Circular perforations42. Volume capacity in centimeters44. Speed bumps46. Cavity of the barrel48. Female thread to be threaded on the male thread of the microbicide tube56. Handle of the plunger58. Shaft of the plunger60. Tip of the plunger62. Raised ledge of the plunger tip50. Disposable tip52. Thread of the disposable tip
[0047]
FIG. 1 shows a front view of the uterus and cervix covered by the intravaginal barrier-type device.
[0048]
FIG. 2 shows a lateral view of the uterus and cervix covered by the Femcap. Cervix 10 is covered by the Femcap and not shown.
[0049]
FIG. 3 shows a cervical view of the Femcap.
[0050]
FIG. 4 shows a lateral view of the Femcap.
[0051]
FIG. 5 shows a vaginal view of the Femcap.
[0052]
FIG. 6 shows a cross section view of the Femcap at a level view.
[0053]
FIG. 7 shows Embodiment A of the vaginal applicator.
[0054]
FIG. 8 shows a barrel of the vaginal applicator.
[0055]
FIG. 9 shows a plunger of the vaginal applicator.
[0056]
FIG. 10 shows the barrel of Embodiment B of the vaginal applicator.
[0057]
FIG. 11 shows a top view of the disposable tip.
[0058]
FIG. 12 shows a side view of the disposable tip
[0059]
FIG. 13 shows the disposable tip threaded to the barrel of the vaginal applicator.
[0060]
FIG. 14 shows another embodiment of the disposable tip.
[0061]
FIG. 15 shows another embodiment of the plunger.
[0062]
One embodiment of the present invention, referred to herein as embodiment 1, is a kit for prevention of conception and sexually transmitted infection, comprising a combination of a barrier-type device, a vaginal applicator for depositing a prophylactic agent onto a desired target area, and a prophylactic agent. In a preferred embodiment of the present invention, the barrier-type device fits over the cervix and blocks entry of sperm and infectious agents from the vaginal canal through the cervical os into the uterus. FIGS. 1 and 2 illustrate the intravaginal, barrier-type device of the present invention covering the cervix to prevent entry of sperm and infectious agents.
[0063]
In the preferred embodiment of the present invention, referred to herein as embodiment 2, the barrier-type device of embodiment 1 comprises a cervical dome fabricated from a flexible material, said dome having an upwardly facing opening and a curved surface extending from said opening to a downwardly facing dome peak, and a continuous, generally annular formical rim defining said opening, said rim being folded from said dome inwardly, upwardly, and outwardly, transitioning therefrom into a continuous, annular vaginal brim which circumscribes said cervical dome and extends both outwardly and downwardly, said formical rim thereby forming an inwardly extending lip and a gel trapping, inwardly extending groove between said brim and said lip, and a strap extending across the dome over the downwardly facing dome peak.
[0064]
FIGS. 3, 4, 5 and 6 illustrate an intravaginal, barrier-type device of the present invention comprising bowl 24, rim 12, brim 16, dome 18, groove 26, strap 20, and lip 28. Preferably, the device is a single piece formed by molding a flexible, physiologically non-reactive material, such as silicone rubber. The cervical dome 18 preferably has a hemi-spherical or hemi-ovoid shape forming a cervical enclosure. At the opening of the enclosure, the dome 18 transitions to a formical rim 12, which in turn, transitions by a backward fold to a vaginal brim 16. An annular lip 28 is formed in the intravaginal, barrier-type device of the present invention by an inward extension of the rim 12 along the periphery of the opening into the dome 18. The lip 28 juts into the opening toward the center line of the dome 18. The backward fold of the rim 12 at the lip 28 by which the rim 12transitions to the brim 16 forms an annular groove 26 between the brim 16 and the dome 18. Strap 20 extends across the dome 18, over the downwardly facing dome peak. Strap 20provides a convenient finger grip for manual removal of the intravaginal, barrier-type device of the present invention. Preferably, the strap 20 is fabricated from the same flexible, physiologically non-reactive material as the device.
[0065]
The relationship of the structure of the barrier-type device of embodiment 2 to female anatomy is illustrated in FIGS. 1 and 2. As shown, the barrier-type device covers the cervix entirely, such that the cervical dome 18 engages the cervix, which extends through the opening defined by the rim 12. The rim 12is seated at the bottom of the fornices. The brim 16 extends from the bottom of the fornices in close sealing engagement with the vaginal walls, therefore continuing a circumferential seal along the vagina forwardly from the fornices. Preferably, the barrier-type device is positioned over the cervix in such way as to orient the annular groove 26 toward the opening of the vagina. Thus oriented, the groove 26 will trap fluids traveling along the inside of the brim 16 toward the dome 18. The strap 20 extends across the dome 18 over the downwardly facing dome peak. In the preferred embodiment, strap 20 is used to manually pull on and remove the barrier-type device from the cervix.
[0066]
When used in conjunction with a prophylactic agent, the intravaginal barrier-type device of the present invention increases the effectiveness of the prophylactic agent by spreading it uniformly all over the cervical and vaginal surfaces in contact with the barrier-type device. In the preferred embodiment, prophylactic agent is deposited into the storage groove 26 and onto the device surfaces in contact with vaginal walls and cervical area. When filled with a prophylactic agent, the groove 26 provides a large surface area which traps and kills sperm and pathogenic organisms upon contact as soon as they enter the vagina.
[0067]
In another embodiment of the present invention, referred to herein as embodiment 3, the vaginal applicator of embodiment 1 comprises a reservoir for holding a prophylactic agent, said reservoir having a proximal end and a distal end, and a perforated tip attached to the distal end, and plunger means attached to the proximal end. FIG. 7 shows a preferred embodiment of the vaginal applicator of the present invention, where a barrel 34 having a proximal end and a distal end is connected to a perforated tip 36 at the distal end, and plunger means 56 at the proximal end. The vaginal applicator 30A is used to deposit a prophylactic agent to a desired target area. Preferably the prophylactic agent is filled into the barrel 34, and is ejected from the barrel 34 through the perforated tip 36by plunger means 56.
[0068]
FIG. 11 shows a close-up of the perforated tip 36 of the vaginal applicator of the present invention, where the tip comprises multiple oval perforations 38 on its surface. The number, size, shape, and location of the perforations may vary. Such variations will be apparent to one of reasonable skill in the art and are within the scope of the present invention. In the preferred embodiment, a single dose of a prophylactic agent ejected through the perforated tip is dispersed through the multiple perforations on the tip. As a result of the multiple perforations, a dose of a prophylactic agent ejected through the perforated tip of the present invention covers a wider desired target area than the same dose ejected through a conventional tip comprising a single hole.
[0069]
In one alternative embodiment, the barrel of the vaginal applicator of embodiment 3 is filled with the prophylactic agent from the proximal end. In another alternative embodiment, the reservoir of the vaginal applicator of embodiment 3 is filled with the prophylactic agent from the distal end. In another alternative embodiment, the vaginal applicator of embodiment 3 is single use. In another alternative embodiment, the vaginal applicator of embodiment 3 is reusable. These and other alternatives are well within the spirit and scope of the present invention.
[0070]
Another embodiment of the present invention, referred to herein as embodiment 4, is the vaginal applicator of embodiment 3, wherein the entire contents of the reservoir are discharged through the perforated tip in a single action of the plunger means. For example, in such embodiment the user has to press the plunger means once for the entire dose of the prophylactic agent held in the reservoir to be ejected through the perforated tip onto the desired target area. In this embodiment, if for example the reservoir maximum capacity is 3 grams and 3 grams of prophylactic agent are contained in the reservoir, a single operation of the plunger means will cause the entire 3 grams dose to be ejected through the perforated tip and onto the desired target area. In one embodiment of the present invention, the vaginal applicator of embodiment 4 is filled with the prophylactic agent from the proximal end. In an alternative embodiment, the vaginal applicator of embodiment 4 is filled from the distal end. In one embodiment, the vaginal applicator of embodiment 4 is single use. In another alternative embodiment, the vaginal applicator of embodiment 4 is reusable. These and other alternatives are well within the spirit and scope of the present invention.
[0071]
An alternative embodiment of the present invention, referred to herein as embodiment 5, is the vaginal applicator of embodiment 3, wherein a pre-determined portion of the entire contents of the reservoir is discharged through the perforated tip in divided doses by multiple actions of the plunger means. For example, in such embodiment the user has to press the plunger more than once in order to the entire dose of prophylactic agent held in the reservoir to be ejected through the perforated tip onto the desired target areas. In this embodiment, if for example the reservoir maximum capacity is 3 grams, the reservoir is filled to capacity, and the vaginal applicator is set to eject 1 gram with each action of the plunger means, then a single operation of the plunger means will cause a 1 gram dose to be ejected through the perforated tip and onto the desired target area. In one embodiment of the present invention, the vaginal applicator of embodiment 5 is filled with the prophylactic agent from the proximal end. In an alternative embodiment, the vaginal applicator of embodiment 5 is filled from the distal end. In one embodiment, the vaginal applicator of embodiment 5 is single use. In another alternative embodiment, the vaginal applicator of embodiment 5 is reusable. These and other alternatives are well within the spirit and scope of the present invention.
[0072]
The kit of the present invention may be used in conjunction with a variety of prophylactic agents currently on the market, including, but not limited to spermicides, microbicides, and virucides. The prophylactic agent used in conjunction with the kit of the present invention may take the form of cream, gel, jelly, or foam. In the preferred embodiment, the kit of the present invention is used in conjunction with Acidform® (gel, available from TOPCAD (Chicago, Ill.). Alternatively, the kit of the present invention may be used in conjunction with various additional spermicidal and microbicidal products not limited to Acidtorm® gel. Alternatively, the kit of the present invention may be used with a prophylactic agent that is a combination of a spermicide and a peroxygen compound. In one embodiment, the kit of the present invention is used in conjunction with a spermicide or microbicide. Practitioners of reasonable skill in the art will be able to choose appropriate prophylactic agents for use in conjunction with the kit of the present invention
[0073]
In the preferred embodiment of the present invention, the prophylactic agent is applied over the interior and exterior surfaces of the intravaginal barrier-type device. In another embodiment, the prophylactic agent is applied both over the surfaces of the barrier-type device and directly over a desired target area of the cervix and the vagina. In one embodiment, the prophylactic agent is applied onto the cervix and the vagina.
[0074]
While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.
[0075]
The inventions illustratively described herein can suitably be practiced in the absence of any element or elements, limitation or limitations, not specifically disclosed herein. Thus, for example, the terms “comprising,” “including,” “containing,” etc. shall be read expansively and without limitation. Additionally, the terms and expressions employed herein have been used as terms of description and not of limitation, and there is no intention in the use of such terms and expressions of excluding any equivalents of the future shown and described or any portion thereof, and it is recognized that various modifications are possible within the scope of the invention claimed. Thus, it should be understood that although the present invention has been specifically disclosed by preferred embodiments and optional features, modification and variation of the inventions herein disclosed can be resorted by those skilled in the art, and that such modifications and variations are considered to be within the scope of the inventions disclosed herein. The inventions have been described broadly and generically herein. Each of the narrower species and subgeneric groupings falling within the scope of the generic disclosure also form part of these inventions. This includes the generic description of each invention with a proviso or negative limitation removing any subject matter from the genus, regardless of whether or not the excised materials specifically resided therein.
REFERENCES
[0076]
The following references are cited in the specification; all of these references are incorporated by this reference in the application in their entirety:1. U.S. Pat. No. 4,858,624 (1989) Shihata2. U.S. Pat. No. 4,989,618 (1991) Shihata3. U.S. Pat. No. 5,207,232 (1993) Shihata4. U.S. Pat. No. 5,778,886 (1998) Shihata5. U.S. Pat. No. 6,706,276 (2004) Garg, et al.6. U.S. Pat. No. 6,239,182 (2001) Zaneveld et al.7. U.S. Pat. No. 6,125,850 (2000) Sokal et al.8. U.S. Pat. No. 6,028,115 (2000) Zaneveld et al.
PATENT CITATIONS
Cited PatentFiling datePublication dateApplicantTitleUS4858624 *Feb 24, 1988Aug 22, 1989Vance Products Incorporated D/B/A/ Cook Urological Incorporated And Cook Ob/GynDevice and method for intravaginal, barrier-type prevention of conception and infectionUS4989618 *Jul 31, 1989Feb 5, 1991Vance Products IncorporatedDevice and method for intravaginal, barrier-type prevention of conception and infectionUS5207232 *Jun 17, 1991May 4, 1993Alfred A. ShihataDevice and method for intravaginal, barrier-type prevention of conception and infectionUS5417224 *May 19, 1993May 23, 1995Advanced Medical Instruments, Inc.Tampon and method for manufacturing the sameUS5592949 *Jun 29, 1994Jan 14, 1997Moench; Thomas R.Device for acidic buffering and method for inactivation of pathogensUS5778886 *Feb 27, 1996Jul 14, 1998Shihata; AlfredVaginal compositions combining a spermicidal agent and a peroxygen compoundUS6230709 *Jun 16, 2000May 15, 2001Lavean Michael G.Cervical cap with hanging loop for removalUS6364854 *Feb 6, 1998Apr 2, 2002J. Uriach & Cia. S. A.Applicator for semi-solid medicationsUS6450986 *Jun 19, 2000Sep 17, 2002Mcneil-Ppc, Inc.Tampon applicator having outwardly flared rimUS6526980 *Aug 25, 2000Mar 4, 2003West Virginia UniversityCervical drug delivery systemUS6936034 *Nov 26, 2003Aug 30, 2005Tasheem WatkinsInsulin syringe with magnified sheathUS20040054332 *Sep 18, 2002Mar 18, 2004Ferguson Gary WilliamSyringe device with resistive ridges and methods of useUS20050045183 *Jun 28, 2004Mar 3, 2005Ovion, Inc.Methods and devices for occluding body lumens and/or for delivering therapeutic agents
* Cited by examiner
CLASSIFICATIONS
U.S. Classification128/833International ClassificationA61F6/12, A61F6/08Cooperative ClassificationA61F6/12, A61F6/08European ClassificationA61F6/08, A61F6/12
LEGAL EVENTS
DateCodeEventDescriptionSep 6, 2007ASAssignment
Owner name: FEMCAP, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SHIHATA, ALFRED;REEL/FRAME:019790/0912
Effective date: 20070723
Owner name: INSTEAD SCIENCES, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FEMCAP, INC.;REEL/FRAME:019790/0902
Effective date: 20070723
Google Home - Sitemap
Agreed! My goal is to have 500k shares, (2.5% of the OS) before the merger is complete. The OS is only 20,000,000 shares!
Looks like a great alternative to the condom. Contraceptive plus STD preventive.
Check out this huge list of patents $LFAP will absorb with the merger! Dr. Alfred Shihata will be a huge addition to the team.
http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Alfred+A.+Shihata%22
Patent for prevention of STD + contraceptive!
https://www.google.com/patents/US20080121238?dq=ininventor:%22Alfred+A.+Shihata%22&hl=en&sa=X&ved=0ahUKEwj4o__tpajNAhUVRVIKHWkCAc0Q6AEINzAE
Up to 4 new products will be created once the merger is complete.
"The LOI also includes utilizing the expertise and experience of FemCap founder Dr. Alfred Shihata. Dr. Shihata brings to the team a wealth of experience in research and development of contraceptive and feminine hygiene medical devices as well as being affiliated with Scripps Institutions of Medicine and Science in San Diego, CA and holding 6 U.S. Patents and numerous international patents, including FemCap and FemmyCycle."